Within the TME, tumor-associated macrophages (TAMs) as the predominant immune population demonstrate progressive upregulation of PD-1/PD-L1 axis activation during tumorigenesis, concurrently driving T cell functional exhaustion and immune checkpoint therapeutic resistance [[154], [155], [156]]. Here, CD274 is linked to neoplasm.